Pérez Salmerón J, Martínez García F, Roldán Conesa D, Lorente Salinas I, López Fornás F, Ruiz Gómez J, Gómez Gómez J, Segovia Hernández M, Valdés Chávarri M
Servicios de Cardiologia y Microbiologia, Hospital Universitario Virgen de la Arrixaca, 30005 Murcia, Spain.
Rev Esp Quimioter. 2006 Sep;19(3):258-66.
The incidence of multidrug-resistant Enterococcus faecium is increasing despite advances in antibacterial therapy. Thus, new antibiotics are required to treat hospital- or community-acquired infections caused by these multidrug-resistant organisms. The aim of this study was to compare the therapeutic efficacy of quinupristin-dalfopristin (QD) alone, or in combination with gentamicin (G), teicoplanin (T), imipenem (I) or levofloxacin (L) against a strain of multidrug-resistant E. faecium in an experimental model of aortic valve endocarditis in rabbits. The study group consisted of 28 control animals. Eighty-two animals were treated with one of the following antibiotic regimens: G1: 18 animals QD (30 mg/kg/8 h); G2: 18 animals QD+G (6 mg/kg/12 h); G3: 16 animals QD+T (20 mg/kg/12 h); G4: 14 animals QD+I (60 mg/kg/8 h); and G5: 16 animals QD+L (20 mg/kg/12 h). The response to therapy was determined by the comparison of the number of CFU/g of E. faecium in each vegetation. In vitro, time-kill studies looking for synergy for the combinations that showed better efficacy in vivo were done. The sensitivity of the strain was intermediate to QD, resistant to T and I, and sensitive to L. There was no high-level resistance to G. QD alone revealed a significant decrease (p <0.001) in the CFU/g in the control group (9.49 vs. 7.31). There were no differences in the average of CFU/g between the QD alone (G1), QD+G (G2) and QD+T (G3) groups. These three groups revealed a significant difference in decrease of CFU/g respect of the group control (p <0.001). There were no differences in the average of CFU/g between QD+I (G4) and QD+T (G5). These two groups revealed the greatest decrease in average CFU/g (G4: 4.38 and G5: 4.04) with differences respect of the group control (p <0.0001) and respect of the groups G1, G2 and G3 (p <0.001). We did not detect any alteration of MIC from QD in the course of the treatment for either of the final isolations. Only the time kill corresponding to concentrations of I 32 mg/l (0.25 x MIC) and QD 1 mg/l (0.25 x MIC presents a descending slope in the curve at 4 and 8 h, suggesting an early synergy phenomenon, which was lost after 8 h. In light of these results, the combination QD with I and L may be considered suitable alternatives for the treatment of multiresistant E. faecium.
尽管抗菌治疗取得了进展,但耐多药屎肠球菌的发病率仍在上升。因此,需要新的抗生素来治疗由这些耐多药微生物引起的医院获得性或社区获得性感染。本研究的目的是在兔主动脉瓣心内膜炎实验模型中,比较单独使用奎奴普丁-达福普汀(QD)或与庆大霉素(G)、替考拉宁(T)、亚胺培南(I)或左氧氟沙星(L)联合使用对一株耐多药屎肠球菌的治疗效果。研究组包括28只对照动物。82只动物接受了以下抗生素治疗方案之一:G1:18只动物使用QD(30mg/kg/8小时);G2:18只动物使用QD+G(6mg/kg/12小时);G3:16只动物使用QD+T(20mg/kg/12小时);G4:14只动物使用QD+I(60mg/kg/8小时);G5:16只动物使用QD+L(20mg/kg/12小时)。通过比较每个赘生物中每克屎肠球菌的CFU数量来确定治疗反应。在体外,对体内显示出更好疗效的组合进行了时间杀菌研究以寻找协同作用。该菌株对QD的敏感性为中度,对T和I耐药,对L敏感。对G没有高水平耐药。单独使用QD时,对照组的CFU/g显著降低(p<0.001)(9.49对7.31)。单独使用QD(G1)、QD+G(G2)和QD+T(G3)组之间每克CFU的平均值没有差异。这三组与对照组相比,CFU/g的降低有显著差异(p<0.001)。QD+I(G4)和QD+T(G5)组之间每克CFU的平均值没有差异。这两组每克CFU的平均值下降最大(G4:4.38和G5:4.04),与对照组相比有差异(p<0.0001),与G1、G2和G3组相比有差异(p<0.001)。在最终分离的任何一种情况下,我们都未检测到QD的MIC有任何变化。只有对应于I浓度为32mg/l(0.25xMIC)和QD浓度为1mg/l(0.25xMIC)的时间杀菌曲线在4小时和8小时出现下降斜率,表明早期协同现象,8小时后消失。鉴于这些结果,QD与I和L的联合使用可能被认为是治疗耐多药屎肠球菌的合适替代方案。